The Parkinson’s Disease Progression Neuroimaging Initiative

The Parkinson’s Disease Progressive Neuroimaging Initiative (PDPNI) is a longitudinal observational clinical study. In PDPNI, the clinical and imaging data of patients diagnosed with Parkinsonian syndromes and Idiopathic rapid eye movement sleep behavior disorder (RBD) were longitudinally followed e...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural neurology 2021-12, Vol.2021, p.2230196-8
Main Authors: Zhu, Shiyi, Ju, Zizhao, Wu, Ping, Liu, Fengtao, Ge, Jingjie, Zhang, Huiwei, Lu, Jiaying, Li, Ling, Wang, Min, Jiang, Jiehui, Wang, Jian, Zuo, Chuantao
Format: Article
Language:English
Subjects:
Biomarkers
Care and treatment
China
Collaboration
Development and progression
Disease Progression
Diseases
Health aspects
Hospitals
Humans
Magnetic Resonance Imaging
Medical research
Medicine, Experimental
Metabolism
Movement disorders
Neuroimaging
Parkinson Disease - diagnostic imaging
Parkinson's disease
PET imaging
REM sleep
REM Sleep Behavior Disorder - diagnostic imaging
Self evaluation
Tomography
Websites
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Parkinson’s Disease Progressive Neuroimaging Initiative (PDPNI) is a longitudinal observational clinical study. In PDPNI, the clinical and imaging data of patients diagnosed with Parkinsonian syndromes and Idiopathic rapid eye movement sleep behavior disorder (RBD) were longitudinally followed every two years, aiming to identify progression biomarkers of Parkinsonian syndromes through functional imaging modalities including FDG-PET, DAT-PET imaging, ASL MRI, and fMRI, as well as the treatment conditions, clinical symptoms, and clinical assessment results of patients. From February 2012 to March 2019, 224 subjects (including 48 healthy subjects and 176 patients with confirmed PDS) have been enrolled in PDPNI. The detailed clinical information and clinical assessment scores of all subjects were collected by neurologists from Huashan Hospital, Fudan University. All subjects enrolled in PDPNI were scanned with 18F-FDG PET, 11C-CFT PET, and MRI scan sequence. All data were collected in strict accordance with standardized data collection protocols.
ISSN:0953-4180
1875-8584
DOI:10.1155/2021/2230196